We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+15.56%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$883B
AUM Growth
+$71.1B
Cap. Flow
-$18.2B
Cap. Flow %
-2.06%
Top 10 Hldgs %
35.83%
Holding
3,193
New
153
Increased
2,010
Reduced
803
Closed
136

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$3.94B
2
AVGO icon
Broadcom
AVGO
+$2.74B
3
MSFT icon
Microsoft
MSFT
+$2.33B
4
AMD icon
Advanced Micro Devices
AMD
+$1.47B
5
GE icon
GE Aerospace
GE
+$1.27B

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$3.42B
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.44B
3
AAPL icon
Apple
AAPL
+$2.42B
4
FISV
Fiserv Inc
FISV
+$2.3B
5
LLY icon
Eli Lilly
LLY
+$1.78B

Sector Composition

Rank Sector Weight
1 Technology 34.73%
2 Financials 12.11%
3 Healthcare 10.97%
4 Consumer Discretionary 10.95%
5 Communication Services 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPI
3026
DELISTED
Office Properties Income Trust
OPI
$23K ﹤0.01%
92,441
BRN icon
3027
Barnwell Industries
BRN
$13.9M
$21K ﹤0.01%
17,735
-465
-3% -$633
LIDR icon
3028
AEye
LIDR
$61.4M
$21K ﹤0.01%
19,680
-516
-3% -$370
CCCC icon
3029
C4 Therapeutics
CCCC
$480M
$18K ﹤0.01%
12,400
-25,743
-67% -$37.4K
MRDN
3030
Meridian Holdings Inc
MRDN
$178M
$18K ﹤0.01%
+877
New +$19.1K
TPIC
3031
DELISTED
TPI Composites
TPIC
$18K ﹤0.01%
21,100
-16,304
-44% -$16.6K
WGSWW
3032
DELISTED
GeneDx Holdings Warrant
WGSWW
$15K ﹤0.01%
243,780
DRRX
3033
DELISTED
DURECT Corp
DRRX
$9K ﹤0.01%
13,846
-364
-3% -$235
KIDZW
3034
KIDZ AI Inc Warrants
KIDZW
$229K
$8K ﹤0.01%
+55,855
New +$8.63K
BGLWW
3035
Blue Gold Ltd Warrant
BGLWW
$690K
$8K ﹤0.01%
+37,850
New +$7.32K
PRPH
3036
DELISTED
ProPhase Labs
PRPH
$7K ﹤0.01%
1,686
-44
-3% -$147
GCTS.WS
3037
GCT Semiconductor Holding Warrants
GCTS.WS
$18.4M
$4K ﹤0.01%
37,675
SRZNW
3038
DELISTED
Surrozen Inc Warrant
SRZNW
$1K ﹤0.01%
41,666
ABOS icon
3039
Acumen Pharmaceuticals
ABOS
$182M
-13,616
Closed -$15K
ACHV icon
3040
Achieve Life Sciences
ACHV
$687M
-13,474
Closed -$36K
AGEN
3041
Agenus
AGEN
$311M
-10,056
Closed -$16K
AKYA
3042
DELISTED
Akoya BioSciences
AKYA
-13,116
Closed -$19K
ALXO icon
3043
ALX Oncology
ALXO
$278M
-10,622
Closed -$7K
AMPY icon
3044
Amplify Energy
AMPY
$182M
-16,842
Closed -$63K
AOK icon
3045
iShares Core Conservative Allocation ETF
AOK
$793M
-2,101
Closed -$791K
APLT
3046
DELISTED
Applied Therapeutics
APLT
-34,763
Closed -$17K
ATNM icon
3047
Actinium Pharmaceuticals
ATNM
$25.8M
-12,785
Closed -$21K
ATOS icon
3048
Atossa Therapeutics
ATOS
$23.5M
-3,413
Closed -$35K
BATRA icon
3049
Atlanta Braves Holdings Series A
BATRA
$3.63B
-4,549
Closed -$200K
BBDC icon
3050
Barings BDC
BBDC
$966M
-119,339
Closed -$1.14M

Similar funds

T. Rowe Price Associates's Q2 2025 Portfolio in Review

As of Q2 2025, T. Rowe Price Associates held 3,193 positions worth $883B, up 8.8% from $812B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

T. Rowe Price Associates's Q2 2025 filing shows 153 new, 2,010 increased, 803 reduced and 136 closed positions. Its largest new stake was Ralliant Corp: 4,667,638 shares worth $226M. The largest sale was Amazon, an estimated $3.42B.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.

  • T. Rowe Price Associates's largest Q2 2025 buy was Ralliant Corp: 4,667,638 shares worth $226M.
  • T. Rowe Price Associates added most to NVIDIA in Q2 2025, an estimated $3.94B increase.
  • T. Rowe Price Associates's biggest Q2 2025 reduction was Amazon, cutting an estimated $3.42B.
  • T. Rowe Price Associates fully exited US Steel in Q2 2025, selling an estimated $146M.
  • T. Rowe Price Associates's ten largest holdings make up 36% of its $883B portfolio in Q2 2025.
  • T. Rowe Price Associates opened 153 new positions and closed 136 in Q2 2025.
  • T. Rowe Price Associates's portfolio value rose 8.8% quarter-over-quarter to $883B.

Based on T. Rowe Price Associates's 13F filing for Q2 2025, filed 14 Aug 2025.